Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$525M |
| 2 |
Microsoft
MSFT
|
+$520M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$447M |
| 4 |
Intel
INTC
|
+$326M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$312M |
Top Sells
| 1 |
Compañía de Minas Buenaventura
BVN
|
+$320M |
| 2 |
CVS Health
CVS
|
+$165M |
| 3 |
Uber
UBER
|
+$143M |
| 4 |
Invesco KBW Bank ETF
KBWB
|
+$124M |
| 5 |
First Trust NASDAQ Cybersecurity ETF
CIBR
|
+$124M |
Sector Composition
| 1 | Technology | 27.25% |
| 2 | Healthcare | 9.94% |
| 3 | Consumer Discretionary | 9.65% |
| 4 | Financials | 8.41% |
| 5 | Communication Services | 6.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Novavax
NVAX
$1.34B
| $8.39M | 0.01% |
1,755,810
+562,053
| +47% | +$2.69M |
|
952
Hasbro
HAS
$10.9B
| $8.37M | 0.01% |
148,091
+13,458
| +10% | +$761K |
|
953
iShares Floating Rate Bond ETF
FLOT
$9.06B
| $8.36M | 0.01% |
163,776
+1,948
| +1% | +$99.5K |
|
954
DraftKings
DKNG
$22.8B
| $8.32M | 0.01% |
183,269
-155,472
| -46% | -$7.06M |
|
955
Fortune Brands Innovations
FBIN
$7.05B
| $8.29M | 0.01% |
97,877
-198,668
| -67% | -$16.8M |
|
956
SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.48B
| $8.29M | 0.01% |
203,474
+187,800
| +1,198% | +$7.65M |
|
957
Rhythm Pharmaceuticals
RYTM
$6.66B
| $8.26M | 0.01% |
190,520
+136,220
| +251% | +$5.9M |
|
958
Ironwood Pharmaceuticals
IRWD
$187M
| $8.25M | 0.01% |
947,710
+585,710
| +162% | +$5.1M |
|
959
Equinor
EQNR
$61.1B
| $8.25M | 0.01% |
305,248
-699,908
| -70% | -$18.9M |
|
960
International Paper
IP
$24.5B
| $8.25M | 0.01% |
211,445
-70,298
| -25% | -$2.74M |
|
961
Dynavax Technologies
DVAX
$1.14B
| $8.25M | 0.01% |
664,527
+191,464
| +40% | +$2.38M |
|
962
KeyCorp
KEY
$21.1B
| $8.24M | 0.01% |
521,372
+18,507
| +4% | +$293K |
|
963
CarMax
KMX
$8.88B
| $8.23M | 0.01% |
94,482
+16,113
| +21% | +$1.4M |
|
964
Meritage Homes
MTH
$5.77B
| $8.23M | 0.01% |
93,768
-13,456
| -13% | -$1.18M |
|
965
Generac Holdings
GNRC
$10.9B
| $8.23M | 0.01% |
65,210
-15,754
| -19% | -$1.99M |
|
|
ALPN
966
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $8.23M | 0.01% |
207,496
+171,719
| +480% | +$6.81M |
|
967
Masimo
MASI
$7.94B
| $8.21M | 0.01% |
55,923
+3,309
| +6% | +$486K |
|
968
US Global Jets ETF
JETS
$834M
| $8.19M | 0.01% |
389,324
+101,456
| +35% | +$2.13M |
|
969
Popular Inc
BPOP
$8.45B
| $8.19M | 0.01% |
92,955
+19,285
| +26% | +$1.7M |
|
970
Celanese
CE
$4.84B
| $8.11M | 0.01% |
47,194
+1,556
| +3% | +$267K |
|
971
TKO Group
TKO
$16B
| $8.08M | 0.01% |
93,476
-62,231
| -40% | -$5.38M |
|
972
Immunovant
IMVT
$2.93B
| $8.07M | 0.01% |
249,791
+125,449
| +101% | +$4.05M |
|
|
SWTX
973
DELISTED
SpringWorks Therapeutics
SWTX
| $8.05M | 0.01% |
163,545
+83,769
| +105% | +$4.12M |
|
974
TG Therapeutics
TGTX
$5.05B
| $8.04M | 0.01% |
528,569
+163,225
| +45% | +$2.48M |
|
975
Arrowhead Research
ARWR
$3.99B
| $8.04M | 0.01% |
280,984
+94,042
| +50% | +$2.69M |
|